April 26th 2024
Fidanacogene elaparvovec-dzkt (Beqvez) is a 1 time treatment that allows patients with hemophilia B to produce factor IX themselves.
Evolving Treatment Landscape of Rett Syndrome: Emerging Therapies to Address Critical Clinical Gaps
1.5 Credits / Rare Diseases
View More
Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intravenous and Subcutaneous Immunoglobulin
1.0 Credit / Immunology, Rare Diseases
View More